# Selective Estrogen Receptor Antagonism
Enclomiphene is the purified stereoisomer (E)-clomiphene, isolated directly from the racemic mixture clomiphene citrate. In the male endocrine system, it functions strictly as a non-steroidal selective estrogen receptor modulator (SERM) with pure antagonist properties at the level of the central nervous system.
## Interruption of Negative Endocrine Feedback
Under typical physiological parameters, circulating estrogen binds to receptors within the hypothalamus and the anterior pituitary gland, exerting a negative feedback loop that signals the body to modulate hormone production. Enclomiphene competitively binds to these central estrogen receptors, preventing endogenous estrogen from attaching.
### Up-Regulation of the HPG Axis Pathway
Because the central nervous system perceives a false state of estrogen deficiency due to this receptor blockade, the hypothalamic-pituitary-gonadal (HPG) axis is up-regulated:
- GnRH Release: The hypothalamus increases the pulsatile secretion of Gonadotropin-Releasing Hormone (GnRH).
- Gonadotropin Stimulation: Elevated GnRH directly prompts the anterior pituitary gland to increase the synthesis and release of two primary gonadotropins: Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH).
#### Downstream Endogenous Synthesis
The subsequent increase in serum LH levels acts directly upon the luteinizing hormone receptors on the Leydig cells within the testes, stimulating the natural, endogenous synthesis of testosterone. Concurrently, the elevation of FSH acts on the Sertoli cells to support the physiological environment necessary for spermatogenesis.
##### Isomeric Isolation Benefits
Unlike traditional clomiphene citrate—which contains approximately 38% zuclomiphene (a stereoisomer with long-lasting, pro-estrogenic agonist properties)—isolated enclomiphene does not accumulate systemic estrogenic activity. This single-isomer approach allows for targeted central antagonism without peripheral estrogen-receptor activation.